Dosage regimen with (s)-4,5-dihydro-2-[2-hydroxy-4-(3,6- dioxaheptyloxy)phenyl1-4-methyl-4-thiazolecarboxylic acid for use in the treatment of iron overload

AL13575BActive Publication Date: 2026-07-01ABFERO PHARMACEUTICALS INC +1
0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
AL · AL
Patent Type
Patents
Current Assignee / Owner
ABFERO PHARMACEUTICALS INC
Filing Date
2026-03-17
Publication Date
2026-07-01
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.